HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparison of the clinical characteristics and hospital treatment of myocardial infarction with and without ST-segment elevation in Hungary. National Registry of Myocardial Infarction].

AbstractINTRODUCTION:
Afew data have been published on the clinical characteristics of different types of myocardial infarction in Hungary.
AIM:
To compare clinical data of patients with ST-segment elevation and non-ST-segment elevation myocardial infarction based on the National Myocardial Infarction Registry database.
METHOD:
Data recorded in the National Myocardial Infarction Registry between January 1, 2010 and June 30, 2012 were included in the analysis.
RESULTS:
Patients treated with non-ST-segment elevation myocardial infarction (n = 5237) were older and had more comorbidities compared to those with ST-segment elevation myocardial infarction (n = 6670). Coronarography and percutaneous coronary intervention were performed more frequently in the latter group. There was no significant difference in in-hospital mortality between the two groups (5.3% and 4.9%). Medication for secondary prevention after myocardial infarction was applied in nearly 90% of the patients in both groups. Dual antiplatelet therapy was more often applied after ST-segment elevation myocardial infarction.
CONCLUSIONS:
The study confirmed important differences in the clinical characteristics and similar hospital prognosis between the two patient groups.
AuthorsTamás Breuer, András Jánosi, Krisztina Szüts, Péter Andréka, Péter Ofner
JournalOrvosi hetilap (Orv Hetil) Vol. 155 Issue 21 Pg. 828-32 (May 25 2014) ISSN: 0030-6002 [Print] Hungary
Vernacular TitleAz ST-elevációval járó és az ST-elevációval nem járó szívinfarktusos betegek klinikai adatainak és kórházi ellátásának összehasonlítása. Nemzeti Szívinfarktus Regiszter.
PMID24836318 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Coronary Angiography
  • Critical Care (methods)
  • Female
  • Heart Conduction System (physiopathology)
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Hungary (epidemiology)
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
  • Male
  • Middle Aged
  • Myocardial Infarction (complications, diagnosis, epidemiology, physiopathology, therapy)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Registries

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: